{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:41:32Z","timestamp":1707525692314},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,5]]},"DOI":"10.7759\/cureus.51725","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T06:18:17Z","timestamp":1704521897000},"source":"Crossref","is-referenced-by-count":0,"title":["Biphasic Peritoneal Mesothelioma Is a Rare Tumor and a Diagnostic Challenge: A Case Report"],"prefix":"10.7759","author":[{"given":"Eihab A","family":"Subahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdalla","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelaziz","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Alsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elrazi A","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagda","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bara","family":"Wazwaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed H","family":"Fadul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Peritoneal mesothelioma: a review","volume":"9","author":"Bridda A","year":"2007","unstructured":"Bridda A, Padoan I, Mencarelli R, Frego M. Peritoneal mesothelioma: a review. MedGenMed. 2007, 9:32.","journal-title":"MedGenMed"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-0588-y","article-title":"Molecular characterization of diffuse malignant peritoneal mesothelioma","volume":"33","author":"Hung YP","year":"2020","unstructured":"Hung YP, Dong F, Torre M, Crum CP, Bueno R, Chirieac LR. Molecular characterization of diffuse malignant peritoneal mesothelioma. Mod Pathol. 2020, 33:2269-79. 10.1038\/s41379-020-0588-y","journal-title":"Mod Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.03.96","article-title":"Malignant peritoneal mesothelioma: a review","volume":"5","author":"Kim J","year":"2017","unstructured":"Kim J, Bhagwandin S, Labow DM. Malignant peritoneal mesothelioma: a review. Ann Transl Med. 2017, 5:236. 10.21037\/atm.2017.03.96","journal-title":"Ann Transl Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2021.100231","article-title":"Phase 2 study of olaparib in malignant mesothelioma and correlation of efficacy with germline or somatic mutations in BAP1 gene","volume":"2","author":"Ghafoor A","year":"2021","unstructured":"Ghafoor A, Mian I, Wagner C, et al.. Phase 2 study of olaparib in malignant mesothelioma and correlation of efficacy with germline or somatic mutations in BAP1 gene. JTO Clin Res Rep. 2021, 2:100231. 10.1016\/j.jtocrr.2021.100231","journal-title":"JTO Clin Res Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14694\/EdBook_AM.2013.33.182","article-title":"Peritoneal mesothelioma: the site of origin matters","volume":"33","author":"Kindler HL","year":"2013","unstructured":"Kindler HL. Peritoneal mesothelioma: the site of origin matters. Am Soc Clin Oncol Educ Book. 2013, 33:182-8. 10.14694\/EdBook_AM.2013.33.182","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-008-0839-2","article-title":"Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma","volume":"14","author":"Tanida S","year":"2009","unstructured":"Tanida S, Kataoka H, Kubota E, et al.. Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma. Int J Clin Oncol. 2009, 14:266-9. 10.1007\/s10147-008-0839-2","journal-title":"Int J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/000313481207800505","article-title":"Localized malignant peritoneal mesothelioma arising in the mesentery of the ascending colon","volume":"78","author":"Kim Y","year":"2012","unstructured":"Kim Y, Lee E, Jung W, Kim HK, Jung SH, Hong KD, Lee Y. Localized malignant peritoneal mesothelioma arising in the mesentery of the ascending colon. Am Surg. 2012, 78:E255-7. 10.1177\/000313481207800505","journal-title":"Am Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22638","article-title":"Biphasic peritoneal mesothelioma: a lethal clinical entity","volume":"14","author":"Waheed A","year":"2022","unstructured":"Waheed A, Foroutan S, McCloskey A, Randhawa H, Cason FD. Biphasic peritoneal mesothelioma: a lethal clinical entity. Cureus. 2022, 14:e22638. 10.7759\/cureus.22638","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2013-0381-RA","article-title":"Malignant mesothelioma diagnosis","volume":"139","author":"Arif Q","year":"2015","unstructured":"Arif Q, Husain AN. Malignant mesothelioma diagnosis. Arch Pathol Lab Med. 2015, 139:978-80. 10.5858\/arpa.2013-0381-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.12.15","article-title":"Peritoneal mesothelioma","volume":"9","author":"Greenbaum A","year":"2020","unstructured":"Greenbaum A, Alexander HR. Peritoneal mesothelioma. Transl Lung Cancer Res. 2020, 9:S120-32. 10.21037\/tlcr.2019.12.15","journal-title":"Transl Lung Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6847","article-title":"Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures","volume":"2","author":"Foster JM","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A, et al.. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. 2019, 2:e186847. 10.1001\/jamanetworkopen.2018.6847","journal-title":"JAMA Netw Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2023.108359","article-title":"Response to nivolumab followed by complete cytoreductive surgery with HIPEC resulted in long-term survival in a patient with sarcomatoid-predominant biphasic peritoneal mesothelioma. A case report","volume":"107","author":"Sugarbaker PH","year":"2023","unstructured":"Sugarbaker PH. Response to nivolumab followed by complete cytoreductive surgery with HIPEC resulted in long-term survival in a patient with sarcomatoid-predominant biphasic peritoneal mesothelioma. A case report. Int J Surg Case Rep. 2023, 107:108359. 10.1016\/j.ijscr.2023.108359","journal-title":"Int J Surg Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2732674","article-title":"Localized biphasic malignant peritoneal mesothelioma with rhabdoid features involving the liver: case report and review of the literature","volume":"2019","author":"Hassan D","year":"2019","unstructured":"Hassan D, Ligato S. Localized biphasic malignant peritoneal mesothelioma with rhabdoid features involving the liver: case report and review of the literature. Case Rep Pathol. 2019, 2019:2732674. 10.1155\/2019\/2732674","journal-title":"Case Rep Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-6293-5","article-title":"Is cytoreductive surgery with hyperthermic intraperitoneal chemotherapy justified for biphasic variants of peritoneal mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry","volume":"25","author":"Votanopoulos KI","year":"2018","unstructured":"Votanopoulos KI, Sugarbaker P, Deraco M, et al.. Is cytoreductive surgery with hyperthermic intraperitoneal chemotherapy justified for biphasic variants of peritoneal mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry. Ann Surg Oncol. 2018, 25:667-73. 10.1245\/s10434-017-6293-5","journal-title":"Ann Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/213517-biphasic-peritoneal-mesothelioma-is-a-rare-tumor-and-a-diagnostic-challenge-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:44Z","timestamp":1707509684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/213517-biphasic-peritoneal-mesothelioma-is-a-rare-tumor-and-a-diagnostic-challenge-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.51725","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,5]]}}}